Cyclacel Pharmaceuticals, Inc. Annual Return On Assets in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
  • Cyclacel Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2025 was -146 %, a 25.9% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2024 was -188 %, a 27% decline from 2023.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2023 was -148 %, a 137% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2022 was -62.5 %, a 57.9% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -188 -40.1 -27% Jan 1, 2024 Dec 31, 2024
2023 -148 -85.7 -137% Jan 1, 2023 Dec 31, 2023
2022 -62.5 -22.9 -57.9% Jan 1, 2022 Dec 31, 2022
2021 -39.6 -7.75 -24.4% Jan 1, 2021 Dec 31, 2021
2020 -31.8 +10.9 +25.5% Jan 1, 2020 Dec 31, 2020
2019 -42.7 -9.58 -28.9% Jan 1, 2019 Dec 31, 2019
2018 -33.1 +1.23 +3.58% Jan 1, 2018 Dec 31, 2018
2017 -34.3 +22.7 +39.8% Jan 1, 2017 Dec 31, 2017
2016 -57.1 -8.43 -17.3% Jan 1, 2016 Dec 31, 2016
2015 -48.6 +9.93 +17% Jan 1, 2015 Dec 31, 2015
2014 -58.6 -27 -85.3% Jan 1, 2014 Dec 31, 2014
2013 -31.6 +29 +47.9% Jan 1, 2013 Dec 31, 2013
2012 -60.6 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.